Association of Atherogenic Indices with Myocardial Damage and Mortality in COVID-19

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 May 16

PMID 38753890

Authors

Seyda Gunay-Polatkan

Serhat Caliskan

Deniz Sigirli

Affiliations

Soon will be listed here.

Abstract

Background: Lipoproteins in cell membranes are related to membrane stability and play a role against microorganisms. Patients with COVID-19 often experience myocyte membrane damage.

Objective: This study aimed to search the relationship of atherogenic indices with myocardial damage and mortality in COVID-19.

Methods: This was an observational, single-center, retrospective study. The study population was grouped according to in-hospital mortality. C-reactive protein (CRP), CRP to albumin ratio (CAR), monocyte to high density lipoprotein cholesterol ratio (MHR), levels of total cholesterol (TC), triglycerides, high-density lipoprotein cholesterol (HDLc), and low-density lipoprotein cholesterol (LDLc) and cardiac troponin I (cTnI) were recorded. Atherogenic indices (plasma atherogenic index [AIP], atherogenic coefficient [AC], Castelli's risk indices I and II [CRI I and II], triglyceride to HDLc ratio (THR) were calculated.

Results: A total of 783 patients were included. The mortality rate was 15.45% (n = 121). The median age of non-survivor group (NSG) was higher than survivor group (SG) [66.0 years (Q1 -Q3: 55.0-77.5) vs 54.0 years (Q1 -Q3: 43.0-63.0)] (p < 0.001). Study parameters which were measured significantly higher in the NSG were CRP, cTnI, triglyceride, CRI-I, CRI-II, AC, AIP, ferritin, CAR, MHR and THR. LDLc, HDLc, TC and albumin were significantly lower in NSG (p<0.001).

Conclusion: THR is positively correlated with myocardial damage and strongly predicts in-hospital mortality in COVID-19.

References

Meilhac O, Tanaka S, Couret D . High-Density Lipoproteins Are Bug Scavengers. Biomolecules. 2020; 10(4). PMC: 7226336. DOI: 10.3390/biom10040598. View

Dobiasova M, Frohlich J . The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001; 34(7):583-8. DOI: 10.1016/s0009-9120(01)00263-6. View

Kim M, Ahn J, Song J, Choi H, Ann H, Kim J . The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy. PLoS One. 2015; 10(7):e0132109. PMC: 4497596. DOI: 10.1371/journal.pone.0132109. View

Kitchens R, Thompson P, Munford R, OKeefe G . Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res. 2003; 44(12):2339-48. DOI: 10.1194/jlr.M300228-JLR200. View

Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K . Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020; 92(5):491-494. PMC: 7166760. DOI: 10.1002/jmv.25709. View

Liu Y, Li G, He J, Liu Y, Li M, Zhang R . Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study. Ann Transl Med. 2020; 8(10):635. PMC: 7290615. DOI: 10.21037/atm-20-2372. View

Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D . Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Med Infect Dis. 2020; 36:101606. PMC: 7102650. DOI: 10.1016/j.tmaid.2020.101606. View

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802-810. PMC: 7097841. DOI: 10.1001/jamacardio.2020.0950. View

Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T . Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020; 158(1):97-105. PMC: 7158802. DOI: 10.1016/j.chest.2020.04.010. View

10.

Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass J . Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020; 11:1648. PMC: 7365905. DOI: 10.3389/fimmu.2020.01648. View

11.

Lin L, Lu L, Cao W, Li T . Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020; 9(1):727-732. PMC: 7170333. DOI: 10.1080/22221751.2020.1746199. View

12.

Yu C, Wong R, Wu E, Kong S, Wong J, Yip G . Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006; 82(964):140-4. PMC: 2596695. DOI: 10.1136/pgmj.2005.037515. View

13.

Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I . High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation. 2006; 114(13):1403-9. DOI: 10.1161/CIRCULATIONAHA.105.607135. View

14.

Lu W, Resnick H, Jablonski K, Jones K, Jain A, Howard W . Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care. 2002; 26(1):16-23. DOI: 10.2337/diacare.26.1.16. View

15.

Ramstedt B, Peter Slotte J . Sphingolipids and the formation of sterol-enriched ordered membrane domains. Biochim Biophys Acta. 2006; 1758(12):1945-56. DOI: 10.1016/j.bbamem.2006.05.020. View

16.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

17.

Wei X, Zeng W, Su J, Wan H, Yu X, Cao X . Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020; 14(3):297-304. PMC: 7192140. DOI: 10.1016/j.jacl.2020.04.008. View

18.

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

19.

Wang G, Zhang Q, Zhao X, Dong H, Wu C, Wu F . Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis. 2020; 19(1):204. PMC: 7475024. DOI: 10.1186/s12944-020-01382-9. View

20.

Barter P, Nicholls S, Rye K, Anantharamaiah G, Navab M, Fogelman A . Antiinflammatory properties of HDL. Circ Res. 2004; 95(8):764-72. DOI: 10.1161/01.RES.0000146094.59640.13. View